Get started
Author

Christy Connor

Observed name: Christy L. Connor
OpenAlex ID: A5084077136
Coronary Artery Calcium Versus Intima-Media Thickness as a Measure of Cardiovascular Disease Among Asymptomatic Adults (from The Rancho Bernardo Study)
2006 · Elizabeth Barrett-Connor, Gail A. Laughlin, et al. · The American Journal of Cardiology · 27
Final safety results from ATHENA–MONO (GOG-3020/ENGOT-ov45), a randomized, placebo-controlled, double-blind, phase 3 trial evaluating rucaparib monotherapy as maintenance treatment in patients with newly diagnosed ovarian cancer.
2024 · David M. O'Malley, Bradley J. Monk, et al. · Journal of Clinical Oncology · 5
Interim post-progression data and updated survival in patients with newly diagnosed advanced ovarian cancer in ATHENA-MONO
2024 · Rebecca Kristeleit, David O'Malley, et al. · Gynecologic Oncology · 3
Impact of germline vs somatic BRCA mutation status on the efficacy of rucaparib vs physician’s choice in the TRITON3 study of patients with metastatic castration-resistant prostate cancer.
2025 · Simon Chowdhury, Alan Haruo Bryce, et al. · Journal of Clinical Oncology · 1
ATHENA-MONO Post-Progression Survival Data Update In Patients With Newly Diagnosed Advanced Ovarian Cancer
2025 · Sharad Ghamande, Rowan E. Miller, et al. · International Journal of Gynecological Cancer
PDF
Abstract C006: LODESTAR: A Single Arm Phase II Study of Rucaparib in Solid Tumors with Pathogenic Germline or Somatic Variants in Homologous Recombination Repair (HRR) Genes
2024 · Sriram Anbil, Nicholas J Seewald, et al. · Cancer Research
176 Rucaparib maintenance treatment in patients (Pts) with newly diagnosed ovarian cancer (OC): defining benefit according to disease risk subgroups within the phase 3 ATHENA-MONO study
2024 · Domenica Lorusso, Rebecca S. Kristeleit, et al. · International Journal of Gynecological Cancer
Works count: 8
Citation count: 63
H-index: 3
I10-index: 2
Year
Topic
Type